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OBJECTIVES We prospectively sought evidence-based criteria that distinguished between seizures and
syncope.
BACKGROUND Loss of consciousness is usually due to either seizures or syncope. There are no evidence-based
historical diagnostic criteria that distinguish them.
METHODS A total of 671 patients with loss of consciousness completed a 118-item historical
questionnaire. Data sets were complete for all subjects. The data set was randomly divided
into two equal groups. The contributions of symptoms to diagnoses in one group were
estimated with logistic regression and point scores were developed. The accuracy of the
decision rule was then assessed using split-half analysis. Analyses were performed with and
without inclusion of measures of symptom burden, which were the number of losses of
consciousness and the duration of the history. The scores were tested using receiver-operator
characteristic analysis.
RESULTS The causes of loss of consciousness were known satisfactorily in 539 patients and included
seizures (n 102; complex partial epilepsy [50 patients] and primary generalized epilepsy [52
patients]) and syncope (n  437; tilt-positive vasovagal syncope [267 patients], ventricular
tachycardia [90 patients] and other diagnoses such as complete heart block and supraven-
tricular tachycardias [80 patients]). The point score based on symptoms alone correctly
classified 94% of patients, diagnosing seizures with 94% sensitivity and 94% specificity.
Including symptom burden did not significantly improve accuracy, indicating that the
symptoms surrounding the loss of consciousness accurately discriminate between seizures and
syncope.
CONCLUSIONS A simple point score of historical features distinguishes syncope from seizures with very high
sensitivity and specificity. (J Am Coll Cardiol 2002;40:142–8) © 2002 by the American
College of Cardiology Foundation
The diagnosis of the cause of transient loss of consciousness
is a common clinical problem. Although symptoms such as
seizure-like activity, tongue-biting and physical trauma are
often used to diagnose a seizure disorder, this practice has
been based upon anecdotal accretion rather than evidence.
The recognition of convulsive syncope has added to the
difficulties of diagnosis. The reliability of the diagnosis of
the first loss of consciousness is surprisingly low (1), but this
can be improved with preset simple diagnostic criteria (2).
Previous attempts at defining diagnostic criteria have been
limited by lack of quantitative data (3), lack of gold standard
diagnostic groups (4,5), lack of populations with both
seizures and syncope (3,4,6–8), retrospective analyses (3,5)
and lack of translation of results into easily applied criteria
(1–7). This frequently leads to laboratory investigations that
may be expensive, invasive and inefficient (9–17).
We hypothesized that evidence-based diagnostic criteria
could distinguish between syncope and seizures as causes of
transient loss of consciousness. To test this we performed
the Syncope Symptom Study. In this prospective study we
administered a uniform questionnaire to 671 patients who
were referred to three academic centers in Canada and
Wales for assessment of transient loss of consciousness. We
first studied patients with securely defined diagnoses based
upon conventionally accepted objective tests. We compared
their responses to identify the historic features that most
accurately correlated with their diagnoses. Here we report
simple historic features that distinguish seizures from syn-
cope with high accuracy.
METHODS
Patient selection. The research ethics committees in all
participating centers approved this study. Patients were
eligible if they have had 1 loss of consciousness and
consented to participate. They were recruited from univer-
sity and private practice neurology and cardiology clinics;
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pacemaker, arrhythmia and syncope clinics; and hospital
cardiology wards. They were included in the main study if
they had a diagnosis established according to preset criteria
and if there was no reasonable diagnostic confusion. All
patients had lost consciousness and at that time had also lost
control of posture. Patients were excluded if they had more
than one plausible cause of syncope. For example, a patient
with lifelong vasovagal syncope and syncope due to ventric-
ular tachycardia (VT) was excluded.
Gold standard diagnostic criteria. Patients had vasovagal
syncope if they had a positive tilt test performed according
to one of several methods (18–22). Patients had a diagnosis
of VT as the cause of syncope if sustained VT was
documented at the time of syncope, or if hemodynamically
unstable, sustained monomorphic VT was induced during a
subsequent electrophysiologic study (23). Patients had tor-
sade de pointes VT if it was documented electrocardio-
graphically at the time of syncope or shortly afterwards.
Patients had complete heart block if complete heart block
with a wide QRS escape rhythm was documented at the
time of syncope or shortly afterwards. Patients had one of
several supraventricular tachyarrhythmias if they had an
established diagnosis of the relevant arrhythmia, and had
their typical symptoms of palpitations immediately preced-
ing a syncopal spell or awoke from syncope with those
symptoms. Orthostatic hypotension was a cause if patients
had a documented autonomic neuropathy with significant
orthostatic hypotension and progressive presyncope during
tilt table testing (24). Complex partial epilepsy or primary
generalized epilepsy was diagnosed if patients had diagnos-
tically positive electroencephalograms (EEGs).
Undiagnosed patients. All patients without an otherwise
proven cause of syncope had an electrocardiogram (ECG)
and a tilt table test. Patients with bifascicular block had a
His bundle conduction study. Patients 60 years usually
underwent ambulatory ECG.
Syncope symptom questionnaire. All patients completed
a structured questionnaire with 118 items developed from
Calkins et al. (6). The questions assessed symptom burden,
provocative situations, perisyncopal symptoms, symptoms
thought to be diagnostic of seizures, signs observed by
bystanders and relevant medical history. Several versions
were tested for clarity and comprehensiveness before the
final version was selected. Completed questionnaires were
checked for completion by study coordinators, and incom-
plete questionnaires were returned for revision. Cross-
checking for incompatible entries assessed the accuracy of
questionnaire completion.
Statistical analysis. We first randomly divided the sample
of 538 patients with secure diagnoses into two halves for the
separate development and testing of the clinical decision
rule. In the development sample (n  270), we compared
the prevalence of each variable in the seizure and syncope
groups using a chi-square test, and calculated the likelihood
ratio for predicting the diagnosis of seizure versus syncope.
The likelihood ratio of each variable is its prevalence in the
seizure group divided by its prevalence in the syncope group.
(The prevalence of a variable in a diagnostic group is
equivalent to its sensitivity for that group. The sensitivity for
seizures is the specificity for syncope and vice versa.) A
variable with a likelihood ratio 1 is predictive of seizure
and a variable with a ratio 1 is predictive of syncope.
We then developed a logistic regression model that
predicted seizures on the basis of the development sample.
Variables were retained in the model if p  0.05 for the
Wald statistic, and a practical diagnostic decision rule was
derived from the regression coefficients (25). A point score
was developed by assigning1,2, or3 points to each of
the factors based on the relative magnitude of the estimated
regression coefficient. Each coefficient was divided by the
smallest absolute value of the coefficient retained in the
model, then rounded to the nearest integer. The points were
then summed and a diagnostic threshold chosen using
receiver-operating characteristic (ROC) analysis (26). Be-
cause this process is equivalent to rounding the estimated
logistic regression coefficients to the nearest integer, there is
a small loss of accuracy. Using the diagnostic threshold, the
apparent sensitivity, specificity and overall accuracy in this
test sample were estimated.
We then tested the decision rule on the test sample of 268
patients. Using the diagnostic threshold established in the
development sample, sensitivity and specificity for seizures
were calculated.
Syncope and seizures often are chronic disorders, and
their symptom burden may be a source of selection bias.
This presents problems if the number of events, or duration
of the history of the disorder, are used as diagnostic criteria.
Therefore, we derived classification rules both with and
without the inclusion of these variables. Finally, it might be
that syncope patients who go on to have a known cause of
syncope have different historic diagnostic features than do
those who do not. Accordingly, we applied the decision rule
to the 132 patients with syncope of unknown cause to assess
the robustness of the classification schemes.
RESULTS
Patient population. There were 102 seizure patients and
569 syncope patients; the latter included 437 with an
established cause. These included vasovagal syncope (267
patients); VT (90 patients); complete heart block (40
patients); supraventricular tachycardias (22 patients); sick
sinus syndrome and hypersensitive carotid sinus syndrome
(4 patients each); aortic stenosis (3 patients); cough syncope,
Abbreviations and Acronyms
ECG  electrocardiogram/electrocardiograph
EEG  electroencephalogram
IQR  interquartile range
ROC  receiver-operating characteristic
VT  ventricular tachycardia
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pulmonary embolus and autonomic neuropathy (2 patients
each) and hyperventilation (1 patient). Of the syncope
patients, 421 had no evidence of structural heart disease and
146 had structural heart disease. There were 52 patients
with primary generalized epilepsy and 50 patients with
complex partial epilepsy. The seizure patients were younger
(35 12 years vs. 53 20 years, p 0.001), but there were
no significant gender differences (44% of the seizure patients
were men, compared with 55% of the syncope patients, p 
0.062). Seizure patients had more episodes of loss of
consciousness (median 168 spells; interquartile range [IQR]
20 to 450) than syncope patients (median 3 spells; IQR 2 to
8; p  0.001). Seizure patients also had a longer history
(median 186 months; IQR 67 to 352) than syncope patients
(median 24 months; IQR 0.33 to 169; p  0.001).
Classifications based on symptoms alone. Table 1 lists
the most important univariate diagnostic features. These
features have a likelihood ratio 2.0 (predictive of seizure)
or 0.5 (predictive of syncope) and had p  0.05. Seizure
patients were more likely to have had a cut tongue, bedwet-
ting, prodromal deja vu, preoccupation, mood changes,
hallucinations or trembling before loss of consciousness,
postictal confusion, muscle pain, headaches, observed con-
vulsive movements, head turning, unresponsiveness during
loss of consciousness and blue skin observed by bystander.
Patients with syncope were more likely to also experience
Table 1. Comparison of the Most Significant Historic Features in Patients With Seizures and Established Diagnoses of Syncope
Sensitivity Specificity Likelihood Ratio
p Value
(Chi-Square)Factors Most Strongly Predictive of Seizures
Cut tongue 0.451 0.973 16.460  0.001
Head turning 0.431 0.968 13.481  0.001
Unusual posturing 0.353 0.973 12.880  0.001
Bedwetting 0.235 0.964 6.447  0.001
Blue color observed by bystanders 0.326 0.944 5.813  0.001
Limb jerking noted by others 0.686 0.877 5.566  0.001
Prodromal trembling 0.294 0.941 4.951  0.001
Prodromal preoccupation 0.078 0.982 4.284 0.002
Prodromal hallucinations 0.078 0.982 4.284 0.002
Behaviors not recalled 0.529 0.868 3.998  0.001
Loss of consciousness associated with stress 0.569 0.849 3.773  0.001
Muscle pain 0.157 0.954 3.433 0.004
Prodromal deja vu 0.137 0.959 3.341 0.009
Observed unresponsiveness 0.765 0.749 3.045  0.001
Postictal confusion 0.941 0.690 3.031  0.001
Postictal headaches 0.490 0.836 2.982  0.001
Prodromal mood changes 0.235 0.918 2.863 0.002
Abnormal behaviors* noted by bystanders 0.922 0.671 2.803  0.001
Factors Most Strongly Predictive Against Seizures
Presyncopal spells before loss of consciousness 0.275 0.274 0.378  0.001
Self-reported high blood pressure 0.098 0.690 0.316 0.002
Presyncope with hot/warm environments 0.078 0.731 0.291 0.004
Presyncope with needle 0.039 0.863 0.286 0.052
Prodromal vertigo 0.059 0.785 0.274 0.010
Any presyncope 0.235 0.137 0.273  0.001
Presynope after exercise 0.078 0.712 0.273 0.002
Hypertension (physician reported) 0.078 0.708 0.268 0.002
Warmth before a spell 0.078 0.662 0.232  0.001
Any chest pain 0.098 0.543 0.215  0.001
Nausea before a spell 0.059 0.722 0.211 0.001
Remembered loss of consciousness 0.118 0.425 0.204  0.001
Presyncope with prolonged sitting/standing 0.059 0.676 0.181  0.001
Diaphoresis before a spell 0.059 0.653 0.169  0.001
Chest pain before a spell 0.020 0.872 0.153 0.025
Palpitations before loss of consciousness 0.039 0.662 0.116  0.001
Dyspnea before loss of consciousness 0.020 0.763 0.083  0.001
Coronary heart disease 0.020 0.749 0.078  0.001
Loss of consciousness with prolonged sitting/standing 0.020 0.603 0.049  0.001
The univariate diagnostic behavior of each of the variables is expressed as its sensitivity, specificity and likelihood ratio for seizures. The likelihood ratio is the probability of a
seizure patient experiencing the symptom divided by the probability of a syncope patient experiencing the symptom. *One or more of witnessed amnesia for abnormal behavior,
witnessed unresponsiveness, unusual posturing or limb jerking. The p value is for the chi-square test for the 2  2 table formed by cross-tabulating the presence or absence of
the factor with the variable indicating syncope/seizure.
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presyncope, have loss of consciousness with prolonged
sitting/standing, or have presyncope with needles, pro-
longed sitting/standing, warm/hot environments and exer-
cise. They were more likely to experience symptoms such as
diaphoresis, dyspnea, chest pain, palpitations, warmth, nau-
sea, vertigo and presyncope before a spell. They were also
more likely to have hypertension, chest pain and coronary
artery disease.
A diagnostic point score was derived from the relative
weighting of the regression coefficients without inclusion of
estimates of symptom burden (Table 2). The diagnostic
behavior of this point score is illustrated in Figure 1. A score
of 1 provides a sharp demarcation between the diagnoses of
syncope and seizures. Patients were classified as having
seizures if their point score was 1. Figure 2 compares the
ROC analysis of the diagnostic point score in the develop-
ment sample and test sample. The diagnostic decision rule,
when applied to patients in the development sample, re-
sulted in an overall accuracy of 96%, with 94% sensitivity for
seizures and 96.3% specificity. In the test sample, the overall
accuracy observed was 94%, with a sensitivity of 94% for
seizures and specificity of 94%.
Classifications based on symptoms and symptom bur-
den. The regression coefficients and derived diagnostic
point scores are listed in Table 3 for the model, including
measures of symptom burden. Features that predicted sei-
zures included a high number of losses of consciousness,
head turning to one side during loss of consciousness, loss of
consciousness with stress and unresponsiveness during loss
of consciousness. Factors that predicted syncope notably
included loss of consciousness after prolonged sitting or
standing, diaphoresis before a spell and presyncope. Using a
cutoff score of 0 to classify patients in the development
sample resulted in an overall accuracy of 86.3%, sensitivity
for seizures of 96% and specificity of 84%. In the test
sample, the overall accuracy observed was 84.7% with a
sensitivity for seizures of 92.1% and specificity of 83%.
The diagnostic behaviors of the two schemes (developed
in the absence and presence of knowledge of symptom
Table 2. Point Scores for the Diagnosis of Seizures, in the
Absence of Knowledge of the Numbers and Historic Duration
of Losses of Consciousness and Lightheaded Spells
Criteria
Regression
Coefficient
(SE)
p
Value Points
Waking with cut tongue 6.85 (2.03) 0.001 2
Abnormal behavior noted* 3.82 (1.37) 0.005 1
Loss of consciousness with
emotional stress
3.97 (1.30) 0.002 1
Postictal confusion 3.52 (1.33) 0.008 1
Head turning to one side during
loss of consciousness
3.67 (1.43) 0.010 1
Prodromal deja vu or jamais vu 2.75 (1.43) 0.055 1
Any presyncope 4.70 (1.34)  0.001 2
Loss of consciousness with
prolonged standing or sitting
5.37 (1.71) 0.002 2
Diaphoresis before a spell 5.73 (1.80) 0.001 2
*Defined in Table 1; classified as seizure for points1. The reported p value is for the
Wald statistic.
SE  standard error.
Figure 1. Sensitivity and specificity for the diagnosis of seizures using point score reported in Table 2. The population is the development sample of patients
with seizures and patients with syncope of known causes.
Figure 2. Receiver-operating characteristic analysis of the diagnostic score
in the development and test samples of patients with seizures and patients
with syncope of known causes.
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burden) were compared with ROC analysis (Fig. 3). The
area under the curve for the classification scheme that did
not account for symptom burden was 0.980, whereas the
area under the curve for the scheme that accounted for
symptom burden was 0.967. Therefore, knowledge of symp-
tom burden did not improve the accuracy of the diagnostic
scheme.
Syncope of unknown cause. Do the risk scores distinguish
patients with seizures from patients with any syncope,
whether or not the cause of the latter is known? We
compared the sensitivity for syncope of the risk scores in
these populations (Fig. 4). The classification scheme diag-
nosed 86% of the 132 patients apparently having syncope of
undiagnosed cause as indeed having syncope. As well, the
scheme behaved almost identically in 437 patients with
syncope of known cause and 132 patients with syncope of
unknown cause as for the 437 gold standard patients alone.
DISCUSSION
This study presents a simple point score of diagnostic
criteria that distinguishes syncope from seizures with high
accuracy. This is a common diagnostic problem for which
no evidence-based classification schemes are available. The
features that clinicians have used to diagnose seizures have
featured symptoms characteristic of specific causes of these
syndromes. For example, diagnostic features of seizures
include myoclonic jerks, tongue biting, tonic spasm, staring,
lip smacking and repetitive facial jerks or grimacing, pro-
dromes of olfactory sensations, head turning or stiffening
and a rising sensation in the abdomen. Criteria for syncope
similarly have been related to specific causes; examples
include nausea, fatigue and specific causal factors for vaso-
vagal syncope. We used a large patient population drawn
from both neurology and cardiology clinics and inpatient
services to establish criteria that would cover a range of
syndromes.
The classification schemes are simple. They provide
evidence for the validity of previous anecdotal approaches
and also illustrate the need for negative criteria. The classic
seizure symptoms and signs of deja vu, cut tongue, limb
jerking and postictal confusion all contributed to the diag-
nosis of seizures. Symptoms of syncope such as prodromal
diaphoresis and palpitations, or provocation by prolonged
sitting or standing, often have needed to be absent to
diagnose a seizure. We had anticipated that the relatively
common occurrence of convulsive syncope might confound
the analysis (12). Indeed, 15% of our patients with syncope
had abnormal limb jerking noted by others. That this was
not a major problem may be because the classification
scheme addresses it directly: to be diagnosed with epileptic
seizures, patients generally have evidence of seizures and
lack evidence of symptoms seen in patients with syncope.
We present sample diagnostic questions and the points
awarded for an affirmative answer in Table 4. Points are
awarded for each answer, and the sum of the points
determines the diagnosis. The patient has seizures if the
point score is 1 and syncope if the point score is 1. We
omitted questions about the severity and duration of the
history of losses of consciousness, because they did not
greatly improve diagnostic accuracy. They might also reflect
referral patterns and the refractory nature of diseases often
seen in tertiary referral clinics, rather than the diagnosis
itself. It is not necessary to know severity or duration to
distinguish between syncope and seizures. Written classifi-
cation schemes may improve diagnostic reliability; in pa-
tients with a transient loss of consciousness there was
substantial diagnostic disagreement among physicians (1,2),
and written diagnostic criteria improved inter-rater agree-
ment.
The diagnostic instrument diagnosed 86% of patients
with apparent syncope of undiagnosed etiology as having
syncope. This slightly lower apparent sensitivity may be due
Table 3. Point Scores for the Diagnosis of Seizures With
Knowledge of the Numbers of Spells and the Length of the
History of Losses of Consciousness and Lightheaded Spells
Criteria
Regression
Coefficient
(SE)
p
Value Points
Loss of consciousness with stress 4.73 (1.43) 0.001 2
Head turning to one side during
loss of consciousness
4.56 (1.84) 0.013 2
Number of spells 30 3.60 (1.02)  0.001 1
Unresponsiveness during loss of
consciousness
3.89 (1.09)  0.001 1
Diaphoresis before loss of
consciousness
2.72 (1.25) 0.029 1
Any presyncope 4.90 (1.30)  0.001 2
Loss of consciousness with
prolonged standing or sitting
7.36 (2.11)  0.001 3
Classify as seizure for point scores 0. The reported p value is for the Wald statistic.
SE  standard error.
Figure 3. Receiver-operating characteristic analysis of the diagnostic score
developed in the absence and presence of knowledge of symptom burden.
The population is the development sample of patients with seizures and
patients with syncope of known causes.
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to different kinds of syncope in this group, or to patients
with true and atypical seizures.
We anticipate that these questions might help with
diagnostic determinations. Although we do not suggest that
they supplant appropriate and targeted investigations in
difficult cases, they may streamline initial patient assess-
ment. This might be useful in a range of clinical and
academic settings, and by preventing some unnecessary
investigations these questions might reduce patient anxiety
and morbidity as well as health costs. Similar analyses are
underway to derive classification schemes for the various
causes of syncope.
Study limitations. There are several factors that might
limit the conclusions. We included only those seizure
patients who had a diagnostic EEG, recognizing that many
patients with seizures have normal interictal EEGs. The
seizure patients were those with loss of consciousness and
postural tone, having either primary generalized seizures or
partial complex seizures. Although there are numerous
other causes of seizures, these are the two most likely to be
confused with convulsive syncope. There might be an
accrual bias in that the patients were identified in tertiary
care clinics and acute care facilities, and a recall bias in
patients’ memories. Similarly, the diagnostic criteria reflect
the numeric balance of patients seen in our study. It might
be that the syncope symptoms are more likely to be
associated with vasovagal syncope rather than with less
common syndromes such as VT. We had few patients with
uncommon causes of syncope, nor did we include patients
with pseudoseizures and patients with more than one
diagnosis. However, the classification schemes do reflect the
prevalence of syndromes and symptoms in tertiary care
referral centers. We did not have a standardized investiga-
tional approach, and it is possible that more diagnoses of
syncope would have been established if all patients, for
example, underwent invasive electrophysiologic studies.
However, these studies have a low yield in patients without
manifest electrical or structural heart disease, and would
serve only to determine the cause of syncope, not whether
the diagnosis was syncope or seizure. Although we validated
each classification scheme through independent confirma-
tion using split-half analysis, this scheme should be vali-
dated externally in patients who present for the first time
with loss of consciousness (2).
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